CSP vs 罕见病患者管理
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CSP
This platform provides a streamlined experience for Chinese pathology professionals to manage conference participation. Users can register, pay, submit work, and book accommodations for society events. Access a wealth of academic content including videos, presentations, and papers.
- Conference registration and payment
- Submission of work
- Hotel booking
- Access academic content
- View video lectures and presentations
- Browse papers and posters
Read full descriptionHide full description
CSP App介绍 这款App是专为中华医学会病理学分会定制的学会服务和管理信息化手机平台。中国病理学专业人士可通过这款App轻松参会,完成所有学会旗下会议注册、缴费、投稿、预定酒店。更可最快速度浏览学会下属学术活动的视频课件、幻灯片、论文、壁报等海量专业学术内容。在线培训模块正在筹划中。我们谨代表中华医学会病理学分会欢迎每位学术同仁开始探索获取学会服务和资讯的崭新体验!
罕见病患者管理
Read full descriptionHide full description
罕见病远程多学科协作机制及智能随访系统
Screenshots
Verdict
The clearest difference is iOS requirement: CSP at 10.0 against 罕见病患者管理's 12.0. On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
CSP ships an update every 2 weeks, 罕见病患者管理 weekly. The most recent releases landed on November 3, 2026 and November 7, 2026 respectively.
| Parameter | CSP | 罕见病患者管理 |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (4 ratings) — better | — |
| Number of ratings | 4 — better | — |
| Update frequency | Every 2 weeks | Weekly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPod | iPhone, iPad, iPod — better |
| Requires iOS | 10.0 — better | 12.0 |
| Further details — not scored | ||
| Size | 136 MB | 32 MB |
| Age rating | 12+ | 17+ |
| Developer | 上海易慧睿思品牌管理咨询有限公司 | 北京协和医院 |
In-app purchases
CSP
No in-app purchases
罕见病患者管理
No in-app purchases









